Advanced search
Publication Cover
Nanomedicine Volume 7, 2012 - Issue 1
Submit an article Journal homepage
570
Views
0
CrossRef citations to date
0
Altmetric
Research Article

P-Glycoprotein Silencing with siRNA Delivered by Dope-Modified Pei Overcomes Doxorubicin Resistance in Breast Cancer Cells

Gemma Navarro1 Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, Boston, MA02115, USA. [email protected]View further author information
,
Rupa R Sawant1 Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, Boston, MA02115, USA. [email protected]View further author information
,
Swati Biswas1 Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, Boston, MA02115, USA. [email protected]View further author information
,
Sean Essex1 Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, Boston, MA02115, USA. [email protected]View further author information
,
Conchita Tros de Ilarduya2 Department of Pharmacy & Pharmaceutical Technology, School of Pharmacy, University of Navarra, 31080Pamplona, SpainView further author information
&
Vladimir P Torchilin1 Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, Boston, MA02115, USA. [email protected]Correspondence[email protected]
View further author information
Pages 65-78 | Published online: 22 Dec 2011

References

  • Gillet JP , GottesmanMM. Mechanisms of multidrug resistance in cancer. Methods Mol. Biol.596, 47–76 (2010).
  • Constantinides PP , WasanKM. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. J. Pharm. Sci.96, 235–248 (2007).
  • Staud F , CeckovaM, MicudaS, PavekP. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics. Methods Mol. Biol.596, 199–222 (2010).
  • Marzolini C , PausE, BuclinT, KimRB. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther.75, 13–33 (2004).
  • Chen H , HaoJ, WangL, LiY. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. Br. J. Cancer101, 432–440 (2009).
  • Lee TB , ParkJH, MinYD, KimKJ, ChoiCH. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy. BMC Gastroenterol.8, 33 (2008).
  • Mahadevan D , ListAF. Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. Blood104, 1940–1951 (2004).
  • Keshet GI , GoldsteinI, ItzhakiOet al. MDR1 expression identifies human melanoma stem cells. Biochem. Biophys. Res. Commun. 368, 930–936 (2008).
  • Leonessa F , ClarkeR. ATP binding cassette transporters and drug resistance in breast cancer. Endocr. Relat. Cancer10, 43–73 (2003).
  • Mechetner E , KyshtoobayevaA, ZonisSet al. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin. Cancer Res. 4, 389–398 (1998).
  • Colabufo NA , BerardiF, CantoreMet al. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials. J. Med. Chem. 53, 1883–1897 (2010).
  • Dantzig AH , de Alwis DP, Burgess M. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy. Adv. Drug Deliv. Rev.55, 133–150 (2003).
  • Lage H . MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr. Drug Targets7, 813–821 (2006).
  • Stege A , KruhnA, LageH. Overcoming multidrug resistance by RNA interference. Methods Mol. Biol.596, 447–465 (2010).
  • Elbashir SM , HarborthJ, LendeckelWet al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  • Grayson AC , DoodyAM, PutnamD. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res.23, 1868–1876 (2006).
  • Hobel S , AignerA. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo. Methods Mol. Biol.623, 283–297 (2010).
  • Neu M , FischerD, KisselT. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med.7, 992–1009 (2005).
  • Ogris M , SteinleinP, CarottaS, BrunnerS, WagnerE. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci.3, E21 (2001).
  • Boussif O , Lezoualc‘hF, ZantaMAet al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92, 7297–7301 (1995).
  • Alshamsan A , HaddadiA, IncaniVet al. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Mol. Pharm. 6, 121–133 (2009).
  • Liu C , ZhaoG, LiuJet al. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. J. Control. Release 140, 277–283 (2009).
  • Gusachenko O , KravchukY, KonevetsDet al. Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification. J. Biomater. Sci. Polym. Ed. 20, 1091–1110 (2009).
  • Han S , MahatoRI, KimSW. Water-soluble lipopolymer for gene delivery. Bioconjug. Chem.12, 337–345 (2001).
  • Abbasi M , LavasanifarA, BerthiaumeLG, WeinfeldM, UludagH. Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein downregulation in tumor cells. Cancer116, 5544–5554 (2010).
  • Rothdiener M , MullerD, CastroPGet al. Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems. J. Control. Release 144, 251–258 (2010).
  • Schafer J , HobelS, BakowskyU, AignerA. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials31, 6892–6900 (2010).
  • Ko YT , KaleA, HartnerWC, Papahadjopoulos-SternbergB, TorchilinVP. Self-assembling micelle-like nanoparticles based on phospholipid–polyethyleneimine conjugates for systemic gene delivery. J. Control. Release133, 132–138 (2009).
  • Navarro G , SawantR, EssexS, Tros de ILarduya C, Torchilin VP. Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery. Drug Deliv. Transl. Res.1, 25–33 (2010).
  • Musacchio T , VazeO, D‘SouzaG, TorchilinVP. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug. Chem.21, 1530–1536 (2010).
  • Wu H , HaitWN, YangJM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res.63, 1515–1519 (2003).
  • Saad M , GarbuzenkoOB, MinkoT. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (Lond.)3, 761–776 (2008).
  • Mao S , NeuM, GermershausOet al. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug. Chem. 17, 1209–1218 (2006).
  • Malek A , CzubaykoF, AignerA. PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy. J. Drug Target16, 124–139 (2008).
  • Kabanov AV , KabanovVA. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug. Chem.6, 7–20 (1995).
  • Grayson AC , DoodyAM, PutnamD. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res.23, 1868–1876 (2006).
  • Peng Z , XiaoZ, WangYet al. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Cancer Gene Ther. 11, 707–712 (2004).
  • Yadav S , van Vlerken LE, Little SR, Amiji MM. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Cancer Chemother. Pharmacol.63, 711–722 (2009).
  • Germano S , O‘DriscollL. Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine. Curr. Cancer Drug Targets9, 398–418 (2009).
  • Jiang J , YangSJ, WangJCet al. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. Eur. J. Pharm. Biopharm. 76, 170–178 (2010).
  • Patil YB , SwaminathanSK, SadhukhaT, MaL, PanyamJ. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials31, 358–365 (2009).
  • Sun TM , DuJZ, YaoYDet al. Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano. 5, 1483–1494 (2011).
  • Philipp A , ZhaoX, TarchaP, WagnerE, ZintchenkoA. Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. Bioconjug. Chem.20, 2055–2061 (2009).
  • Yamazaki Y , NangoM, MatsuuraMet al. Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine. Gene Ther. 7, 1148–1155 (2000).
  • Chen JL , WangH, GaoJQ, ChenHL, LiangWQ. Liposomes modified with polycation used for gene delivery: preparation, characterization and transfection in vitro. Int. J. Pharm.343, 255–261 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.